COLORADO SPRINGS, CO, UNITED STATES, January 14, 2026 /EINPresswire.com/ -- Lahjavida Bio, a biotechnology company ...

CraniUS Therapeutics announced today that it raised $20 million in a Series B financing round to accelerate the development ...

Announcing a new article publication for BIO Integration journal. Pulmonary fibrosis (PF) is a progressive interstitial lung disease characterized by excessive extracellular matrix deposition and ...

Key market opportunities include leveraging molecular switches for targeted drug delivery systems and therapies in oncology, autoimmune, inflammatory, and neurological disorders. Innovations in ...

In the evolving landscape of pharmaceutical development, modified release (MR) tablets have emerged as a cornerstone technology for improving therapeutic outcomes and patient compliance. Unlike ...

Delivering therapies to the brain remains a major challenge due to the limited permeability of the blood-brain barrier. In a ...

Researchers have demonstrated that microscopic drug delivery containers can be magnetically steered to their targets, advancing the development of precision medicine for treating diseases such as ...

VANCOUVER, BC, BC / ACCESS Newswire / October 2, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a development-stage biopharmaceutical company specializing ...

Nanoparticles enhance drug solubility, stability, and bioavailability, improving therapeutic outcomes for GI conditions like IBD through targeted delivery mechanisms. Hydrogel-based systems offer ...

Nanogels are increasingly used in drug delivery systems for their ability to encapsulate a wide range of therapeutic agents and release them in a controlled, targeted manner. Recent developments have ...